CSI Market
Sign In | Register

Bionexus Gene Lab (BGLC) Annual Balance Sheets

Annual · GAAP · USD millions
Access BGLC quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Bionexus Gene Lab's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.00
Deposits Assets, Current AS1.66
Cash & Short-term Investments1.00
Accounts receivable0.51
Other Receivables, Net, Current0.08
Income Taxes Receivable, Current NO0.06
Inventories0.68
Other Current Assets2.47
Total Current Assets5.45
Equipment/Property/Plant Net1.60
Long-term investments2.03
Other Assets, Noncurrent2.21
Trade Receivables-
Operating Lease Right Of Use Asset0.18
Total Assets9.25
Liabilities
Accounts Payable, Trade, Current0.00
Other Accounts Payable AndAccrued Liabilities0.40
Other Liabilities, Current0.00
Taxes Payable, Current, Total0.00
Customer Advances, Current0.01
Total Current Liabilities0.52
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.00
Amount Owing To Director Current0.05
Operating Lease Liability Current0.06
Finance Lease Liability Noncurrent-
Operating Lease Liability Noncurrent0.12
Deferred Income Tax Liabilities Net-
Total Liabilities0.64
Stockholders' Equity
Common Stock Value20.17
Additional Paid In Capital Common Stock-5.01
Retained Earnings / Accumulated Deficit-6.43
Other Equity-0.12
Common Stockholder's Equity8.61
Total Stockholder's Equity8.61
Liabilities & Stockholder's Equity9.25
4 historic quarters locked

Sign in to unlock the full Bionexus Gene Lab balance sheet history.

Sign In Create Free Account

About Bionexus Gene Lab Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: April 14, 2026
  • Source: bglc_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001477932-26-002218

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License